The Cooper Companies, Inc. (COO) Quick Ratio (Acid-Test): 1.13
Is The Cooper Companies, Inc.’s quick ratio (acid-test) high or low?
The Cooper Companies, Inc.'s quick ratio (acid-test) of 1.13 is 16% above its 5-year average of 0.98, near the high end of its 5-year range (0.70–1.20).
As of Sunday, June 14, 2026. 0.44% above its 12-month average of 1.13.
COO Quick Ratio (Acid-Test) Chart
COO Average Quick Ratio (Acid-Test) Chart
COO Current vs Average Quick Ratio (Acid-Test) Chart
COO Quick Ratio (Acid-Test) Metrics
QUICK RATIO (ACID-TEST)
1.13
QUICK RATIO (ACID-TEST) AVG TTM
1.13
QUICK RATIO (ACID-TEST) AVG 3Y
0.99
QUICK RATIO (ACID-TEST) AVG 5Y
0.98
QUICK RATIO (ACID-TEST) AVG 10Y
0.96
QUICK RATIO (ACID-TEST) AVG 15Y
1.03
QUICK RATIO (ACID-TEST) AVG 20Y
1.02
CURRENT VS TTM AVG
+0.44%
CURRENT VS 3Y AVG
+14.14%
CURRENT VS 5Y AVG
+15.70%
CURRENT VS 10Y AVG
+17.49%
CURRENT VS 15Y AVG
+9.84%
CURRENT VS 20Y AVG
+10.53%
COO Competitors' Quick Ratio (Acid-Test)
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $13.24B | 1.13 | 1.13 | 0.99 | 0.98 |
| Solventum Corporation (SOLV) | $13.66B | 0.89 | 0.86 | 0.93 | 0.94 |
| Align Technology, Inc. (ALGN) | $12.52B | 1.24 | 1.17 | 1.11 | 1.16 |
| Baxter International Inc. (BAX) | $10.77B | 1.56 | 1.31 | 1.23 | 1.40 |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | 0.37 | 0.33 | 0.35 | 0.35 |
| Hologic, Inc. (HOLX) | $16.97B | 3.06 | 3.04 | 3.12 | 2.66 |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 1.02 | 1.07 | 1.10 | 1.11 |
| Tempus AI, Inc. (TEM) | $8.35B | 3.00 | 2.58 | 2.23 | 3.05 |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 4.19 | 4.52 | 4.42 | 3.69 |
| Moderna, Inc. (MRNA) | $19.80B | 3.22 | 3.42 | 3.19 | 2.63 |
Liquidity Comparison
Quick Ratio
1.13
Excludes inventory
Current Ratio
1.89
Includes inventory
The Cooper Companies, Inc. Quick Ratio (Acid-Test) Formula & Definition
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
The Cooper Companies, Inc. Quick Ratio (Acid-Test) FAQ
- What is the quick ratio (acid-test) for The Cooper Companies, Inc. (COO)?
- The quick ratio (acid-test) for COO stock is 1.13.
- Is The Cooper Companies, Inc.'s quick ratio (acid-test) high or low?
- The Cooper Companies, Inc.'s quick ratio (acid-test) of 1.13 is 16% above its 5-year average of 0.98, near the high end of its 5-year range (0.70–1.20).
- What is the TTM average quick ratio (acid-test) for The Cooper Companies, Inc. (COO)?
- The TTM average quick ratio (acid-test) for COO stock is 1.13.
- What is the 3Y average quick ratio (acid-test) for The Cooper Companies, Inc. (COO)?
- The 3Y average quick ratio (acid-test) for COO stock is 0.99.
- What is the 5Y average quick ratio (acid-test) for The Cooper Companies, Inc. (COO)?
- The 5Y average quick ratio (acid-test) for COO stock is 0.98.
- What is the 10Y average quick ratio (acid-test) for The Cooper Companies, Inc. (COO)?
- The 10Y average quick ratio (acid-test) for COO stock is 0.96.
- What is the 15Y average quick ratio (acid-test) for The Cooper Companies, Inc. (COO)?
- The 15Y average quick ratio (acid-test) for COO stock is 1.03.
- What is the 20Y average quick ratio (acid-test) for The Cooper Companies, Inc. (COO)?
- The 20Y average quick ratio (acid-test) for COO stock is 1.02.
The Cooper Companies, Inc. Quick Ratio (Acid-Test) History
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-10-31 | 1.13 |
| 2024-10-31 | 1.12 |
| 2023-10-31 | 1.00 |
| 2022-10-31 | 0.71 |
| 2021-10-31 | 1.20 |
| 2020-10-31 | 0.70 |
| 2019-10-31 | 0.59 |
| 2018-10-31 | 1.16 |
| 2017-10-31 | 1.26 |
| 2016-10-31 | 0.96 |
| 2015-10-31 | 0.75 |
| 2014-10-31 | 0.93 |
| 2013-10-31 | 1.27 |
| 2012-10-31 | 1.29 |
| 2011-10-31 | 1.07 |
| 2010-10-31 | 1.32 |
| 2009-10-31 | 1.39 |
| 2008-10-31 | 0.95 |
| 2007-10-31 | 0.87 |
| 2006-10-31 | 0.80 |
| 2005-10-31 | 1.00 |
| 2004-10-31 | 1.69 |
| 2003-10-31 | 1.47 |
| 2002-10-31 | 0.97 |
| 2001-10-31 | 1.53 |
| 2000-10-31 | 1.14 |
| 1999-10-31 | 1.60 |
| 1998-10-31 | 1.84 |
| 1997-10-31 | 1.59 |
| 1996-10-31 | 0.96 |
Related Metrics
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White